Compile Data Set for Download or QSAR

Found 4 hits Enz. Inhib. hit(s) with Target = 'Protein kinase C beta type' and Ligand = 'BDBM3202'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Protein kinase C beta type (Homo sapiens (Human))	BDBM3202 ((+-)-anti-2-[[2,6-Dihydroxy-4-[[[2-(4-hydroxypheny...) Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Oc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H22O10/c27-14-7-9-15(10-8-14)35-20-5-2-6-21(20)36-26(34)13-11-18(29)23(19(30)12-13)24(31)22-16(25(32)33)3-1-4-17(22)28/h1,3-4,7-12,20-21,27-30H,2,5-6H2,(H,32,33)/t20-,21-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				J Med Chem 39: 5215-27 (1996) Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV
					More data for this Ligand-Target Pair
Protein kinase C beta type (Homo sapiens (Human))	BDBM3202 ((+-)-anti-2-[[2,6-Dihydroxy-4-[[[2-(4-hydroxypheny...) Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Oc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H22O10/c27-14-7-9-15(10-8-14)35-20-5-2-6-21(20)36-26(34)13-11-18(29)23(19(30)12-13)24(31)22-16(25(32)33)3-1-4-17(22)28/h1,3-4,7-12,20-21,27-30H,2,5-6H2,(H,32,33)/t20-,21-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of protein kinase C alpha				Bioorg Med Chem Lett 6: 1759-1764 (1996) Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R
					More data for this Ligand-Target Pair
Protein kinase C beta type (Homo sapiens (Human))	BDBM3202 ((+-)-anti-2-[[2,6-Dihydroxy-4-[[[2-(4-hydroxypheny...) Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Oc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H22O10/c27-14-7-9-15(10-8-14)35-20-5-2-6-21(20)36-26(34)13-11-18(29)23(19(30)12-13)24(31)22-16(25(32)33)3-1-4-17(22)28/h1,3-4,7-12,20-21,27-30H,2,5-6H2,(H,32,33)/t20-,21-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of protein kinase C beta I				Bioorg Med Chem Lett 6: 1759-1764 (1996) Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R
					More data for this Ligand-Target Pair
Protein kinase C beta type (Homo sapiens (Human))	BDBM3202 ((+-)-anti-2-[[2,6-Dihydroxy-4-[[[2-(4-hydroxypheny...) Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Oc1ccc(O)cc1 |r| Show InChI InChI=1S/C26H22O10/c27-14-7-9-15(10-8-14)35-20-5-2-6-21(20)36-26(34)13-11-18(29)23(19(30)12-13)24(31)22-16(25(32)33)3-1-4-17(22)28/h1,3-4,7-12,20-21,27-30H,2,5-6H2,(H,32,33)/t20-,21-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Sphinx Laboratories					Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.				J Med Chem 39: 5215-27 (1996) Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV
					More data for this Ligand-Target Pair